0.012
Vincerx Pharma Inc Azioni (VINC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
35.15%
7.478
|
5.533 | 10.32 | 11.66 | 15.10 |
| Operating Income/Loss |
35.15%
-7.478
|
-5.533 | -10.32 | -11.66 | -15.10 |
| Nonoperating Income/Loss |
949.23%
-4.951
|
0.583 | 0.602 | 0.509 | 0.758 |
| Income/Loss From Continuing Operations Before Tax |
151.09%
-12.43
|
-4.95 | -9.715 | -11.15 | -14.34 |
| Income/Loss From Continuing Operations After Tax |
151.09%
-12.43
|
-4.95 | -9.715 | -11.15 | -14.34 |
|
|
151.09%
-12.43
|
-4.95 | -9.715 | -11.15 | -14.34 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
82,208%
0.0214
|
0.000026 | 0.0213 | 0.0213 | 0.0212 |
| Diluted Average Shares |
82,208%
0.0214
|
0.000026 | 0.0213 | 0.0213 | 0.0212 |
| Basic Earnings Per Share |
152.17%
-0.58
|
-0.23 | -0.46 | -0.52 | -0.68 |
| Diluted Earnings Per Share |
152.17%
-0.58
|
-0.23 | -0.46 | -0.52 | -0.68 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):